| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.01. | Ein ganzheitlicher Beratungsansatz für bAV, bKV und bAKS | 68 | AssCompact | Die moderne Firmenkundenberatung geht über den reinen Produktverkauf hinaus hin zu einer umfassenden Beratung in allen relevanten Aspekten. Für die ALH Gruppe gehören zu einem ganzheitlichen Versorgungskonzept... ► Artikel lesen | |
| 07.01. | Tincorp Metals Inc.: Tincorp Announces Credit Facility and Cancels Private Placement | 257 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - January 8, 2024) - Tincorp Metals Inc. (TSXV: TIN) (OTCQX: TINFF) ("Tincorp" or the "Company") announces that it has entered into an interest-free unsecured... ► Artikel lesen | |
| 07.01. | Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Milestones for 2024 | 224 | Business Wire | ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced its preliminary unaudited financial results for the fiscal year 2023, provided financial guidance for fiscal year... ► Artikel lesen | |
| 07.01. | Hologic Announces Preliminary Revenue Results for First Quarter of Fiscal 2024 | 261 | Business Wire | MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today preliminary revenue results for its first fiscal quarter ended December 30, 2023.
The Company expects to report... ► Artikel lesen | |
| 07.01. | Ascendis Pharma Introduces Vision 2030 | 448 | GlobeNewswire (Europe) | Strategic roadmap to achieve blockbuster status for multiple products and expand the Company's engine for future innovation COPENHAGEN, Denmark, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Ascendis Pharma... ► Artikel lesen | |
| 07.01. | Singular Genomics Systems, Inc.: Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2023 Revenue | 238 | GlobeNewswire (Europe) | SAN DIEGO, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers... ► Artikel lesen | |
| 07.01. | Amicus Therapeutics, Inc.: Amicus Therapeutics Reports Preliminary 2023 Revenue and Provides 2024 Strategic Outlook | 671 | GlobeNewswire (Europe) | 2023 Total Revenue of ~$399.4M, a 21% Increase Year-Over-Year >2,400 People Living with Fabry Disease on Galafold® Following a Year of Increased Demand Expecting 2024 Galafold Revenue Growth of 11-16%... ► Artikel lesen | |
| 07.01. | Vincerx Pharma, Inc.: Vincerx Pharma Announces Compelling Clinical Efficacy of Enitociclib in Combination with Venetoclax and Prednisone in Lymphoma | 309 | GlobeNewswire (Europe) | Investigators from the National Institutes of Health (NIH) report 2 partial responses (PR) in 3 peripheral T-cell lymphoma (PTCL) patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma (DH-DLBCL)... ► Artikel lesen | |
| 07.01. | QIAGEN N.V.: QIAGEN announces plans to return approximately $300 million to shareholders | 863 | GlobeNewswire (Europe) | Venlo, the Netherlands, Jan. 07, 2024 (GLOBE NEWSWIRE) -- QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a plan to return up to approximately $300 million (maximum EUR 273... ► Artikel lesen | |
| 07.01. | Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance | 228 | GlobeNewswire (Europe) | CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for... ► Artikel lesen | |
| 07.01. | Pandora A/S: Pandora exceeds guidance: Strong Q4 sales lift full year organic growth to 8% | 598 | GlobeNewswire (Europe) | Following a strong end to 2023 with double-digit organic growth in the fourth quarter and solid profitability, the preliminary and unaudited results for 2023 exceed the full-year guidance communicated... ► Artikel lesen | |
| 07.01. | Ultragenyx Pharmaceutical Inc.: Ultragenyx Reports Preliminary 2023 Revenue; Guidance for 2024 Revenue and Cash Usage; Pipeline Updates and 2024 Milestones | 174 | GlobeNewswire (Europe) | Preliminary 2023 Total Revenue of $430 million to $435 million, Crysvita® Revenue of $325 million to $330 million and Dojolvi® revenue of $70 million to $71 million 2024 expected Total Revenue guidance... ► Artikel lesen | |
| 07.01. | Caribou Biosciences, Inc.: Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024 | 244 | GlobeNewswire (Europe) | -- Tim Kelly to lead Caribou's technical operations strategy and execution -- -- CB-010 ANTLER Phase 1 trial initial dose expansion data and RP2D to be disclosed Q2 2024; Caribou plans to initiate... ► Artikel lesen | |
| 07.01. | RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance | 329 | GlobeNewswire (Europe) | ALISO VIEJO, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| 07.01. | Akoya Biosciences, Inc.: Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform | 169 | GlobeNewswire (Europe) | MaxFuse enables matching and integration of datasets from spatial proteomics, spatial transcriptomics, single-cell sequencing, or other modalities Development and application of MaxFuse were described... ► Artikel lesen | |
| 07.01. | Akoya Biosciences, Inc.: Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook | 244 | GlobeNewswire (Europe) | MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) ("Akoya"), The Spatial Biology Company®, today announced preliminary unaudited revenue for the fourth quarter... ► Artikel lesen | |
| 07.01. | Gentex Corporation: Gentex Announces eSight Acquisition Set to Showcase Advanced Vision Tech at CES 2024 | 365 | GlobeNewswire (Europe) | LAS VEGAS, Jan. 07, 2024 (GLOBE NEWSWIRE) -- Gentex Corporation (NASDAQ: GNTX) announced today the asset acquisition of eSight, a leading provider of vision enhancement technologies, to develop and... ► Artikel lesen | |
| 07.01. | Akoya Biosciences, Inc.: Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow | 458 | GlobeNewswire (Europe) | MARLBOROUGH, Mass., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company®, today announced that it has entered into a license and distribution agreement... ► Artikel lesen | |
| 07.01. | Heron Therapeutics, Inc.: Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain | 173 | PR Newswire | SAN DIEGO, Jan. 7, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that it has entered into a five-year distributor partnership... ► Artikel lesen | |
| 07.01. | Exact Sciences Corporation: Exact Sciences Announces Preliminary Fourth Quarter 2023 Results | 532 | PR Newswire | Anticipates record fourth-quarter revenue, expects full-year 2024 revenue of $2.83 billion, submits next-generation Cologuard® to FDA
Announces Chief Financial Officer succession plan
Highlighted announcements:
Expects... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 8.064 |
| EVOTEC | 4.020 |
| BAYER | 3.075 |
| SUPER MICRO COMPUTER | 3.005 |
| NEL | 2.470 |
| MICROSTRATEGY | 1.532 |
| RHEINMETALL | 1.462 |
| TUI | 1.292 |
| TESLA | 1.245 |
| THYSSENKRUPP | 1.120 |
| PALANTIR TECHNOLOGIES | 1.045 |
| PORSCHE AG | 1.007 |
| BIONTECH | 935 |
| VOLKSWAGEN | 926 |
| RENK GROUP | 911 |
| COMMERZBANK | 693 |
| AIXTRON SE | 689 |
| COINBASE GLOBAL | 679 |
| DEUTSCHE BANK | 673 |
| GAMESTOP | 664 |
| BYD | 650 |
| MERCEDES-BENZ | 612 |
| BASF | 599 |
| JINKOSOLAR | 584 |
| AMAZON | 571 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
